Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
62.75    0.00 (0.00%)
Bid:
61.50
Ask:
64.00
Spread: 2.50 (4.065%)
Market Cap: £5.76m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Form 8.3 - CPP Group plc

1 Nov 2012 12:05

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A

PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/ Aberforth Partners LLP, on dealings are being disclosed:

behalf of discretionary clients. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to CPP Group PLC whose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: 31 October 2012 (f) Has the discloser previously disclosed, or Y/N NO are they today disclosing, under the Code in

respect of any other party to this offer? If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned 6,809,770 3.97 0 0.0 and/or controlled: (2) Derivatives (other than options): (3) Options and agreements to purchase/sell: TOTAL: 6,809,770* 3.97* 0 0.0

*Of this total holding, voting rights are held over 5,125,870 shares (2.99%)

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in N/A relation to which subscription right exists: Details, including nature of the N/A rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit security securities N/A- Opening Disclosure

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option relevant description purchasing, securities price

date money security e.g. call selling, to which per unit e.g. paid/

option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per

security description securities unit e.g. call option N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit

security (if applicable) e.g. subscription, conversion N/A

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None (c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached? Y/N NO Date of disclosure: 01 November 2012 Contact name: Pauline Robson, for Aberforth Partners LLP Telephone number: 0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk . The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

XLON
Date   Source Headline
2nd Nov 20174:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20179:45 amRNSHolding(s) in Company
2nd Nov 20179:17 amRNSDirector/PDMR Shareholding
30th Oct 20174:45 pmRNSChange of Registered Office
27th Oct 201711:45 amRNSDirector/PDMR Shareholding
25th Oct 201712:20 pmRNSDirector/PDMR Shareholding
24th Aug 20177:00 amRNSHalf-year Report
11th Aug 20172:14 pmRNSBlock listing Interim Review
1st Aug 201712:50 pmRNSDirectorate Change
27th Jun 201710:15 amRNSStatement re Card Protection Plan Limited
21st Jun 201710:00 amRNSBlock listing Interim Review
20th Jun 20172:18 pmRNSAdditional Listing
19th May 20173:01 pmRNSResult of AGM
16th May 201710:30 amRNSStatement re Homecare Insurance Limited
21st Apr 20172:28 pmRNSDirector/PDMR Shareholding
19th Apr 20177:00 amRNSDirectorate Change
18th Apr 201710:08 amRNSDirector/PDMR Shareholding
13th Apr 20179:00 amRNSNotice of AGM
12th Apr 20174:43 pmRNSDirector/PDMR Shareholding
29th Mar 20175:57 pmRNSHolding(s) in Company
29th Mar 20175:27 pmRNSDirector/PDMR Shareholding
24th Mar 20177:00 amRNSDirectorate Change
24th Mar 20177:00 amRNSAnnual Financial Report
17th Mar 20177:00 amRNSAcquisition
13th Feb 201712:08 pmRNSBlock listing Interim Review
30th Jan 20174:41 pmRNSSecond Price Monitoring Extn
30th Jan 20174:37 pmRNSPrice Monitoring Extension
17th Jan 201712:05 pmRNSPrice Monitoring Extension
30th Dec 20163:33 pmRNSStatement re IT Platform
23rd Dec 20162:23 pmRNSHolding(s) in Company
16th Dec 20169:41 amRNSBlock listing Interim Review
8th Dec 20164:41 pmRNSSecond Price Monitoring Extn
8th Dec 20164:37 pmRNSPrice Monitoring Extension
7th Dec 20164:36 pmRNSPrice Monitoring Extension
18th Nov 20167:00 amRNSTrading Statement
14th Sep 20165:16 pmRNSStatement re IT Platform
18th Aug 20167:00 amRNSHalf-year Report
15th Aug 201611:40 amRNSBlock listing Interim Review
26th Jul 20166:19 pmRNSDirectorate Change
6th Jul 20164:00 pmRNSHolding(s) in Company
5th Jul 20169:15 amRNSTotal Voting Rights
21st Jun 201612:44 pmRNSAdditional Listing
17th Jun 20169:53 amRNSBlock listing Interim Review
19th May 20167:00 amRNSDirectorate Change
18th May 20164:50 pmRNSResult of AGM
18th May 20167:00 amRNSChange of Adviser
16th May 20165:23 pmRNSAGM Statement
16th May 20167:00 amRNSDirectorate Change
9th May 20163:19 pmRNSAGM Statement
6th May 20164:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.